Prevalence of antibodies against Trypanosoma cruzi in blood bank donors from the IMSS General Hospital in Orizaba, Veracruz, Mexico;Prevalencia de anticuerpos contra Trypanosoma cruzi en donadores de sangre del IMSS, Orizaba, Veracruz, México

Salud Publica de Mexico

Volumn 48, Issue 1, 2006, Pages 13-21

  Ramos Ligonio, Angel ^a   Ramírez Sánchez, Michaía Elián ^a   González Hernández, Juan Carlos ^a   Rosales Encina, José Luis ^b   López Monteon, Aracely ^a  

^a UNIVERSIDAD VERACRUZANA   (Mexico)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Chagas disease; Mexico; Recombinant protein; Serodiagnosis

Indexed keywords

HEAT SHOCK PROTEIN 70; RECOMBINANT PROTEIN;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; BLOOD ANALYSIS; BLOOD BANK; BLOOD DONOR; BLOOD SAMPLING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIMASTIGOTE; GENERAL HOSPITAL; HUMAN; IMMUNOFLUORESCENCE TEST; MEXICO; NONHUMAN; NORMAL HUMAN; PARASITE PREVALENCE; PREVALENCE; SOCIAL SECURITY; TRYPANOSOMA CRUZI; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; ANIMALS; ANTIBODIES, PROTOZOAN; BLOOD BANKS; BLOOD DONORS; CHAGAS DISEASE; FEMALE; HUMANS; MALE; MEXICO; MIDDLE AGED; SEROEPIDEMIOLOGIC STUDIES; TRYPANOSOMA CRUZI;

EID: 33645310169     PISSN: 00363634     EISSN: 16067916     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Schofield CJ, Dias JCP. Introduction and historical overview. En: Schofield CJ, Dujardin JP, Jurberg J. ed. Taller Internacional sobre Genética Poblacional y Control de Triatominos. México, D.F.: INDRE, 1996:11-16.
2. Schumis GA. La tripanosomiasis americana como problema de salud pública. En: La enfermedad de Chagas y el sistema nervioso. Washington, D.C.: Organización Panamericana de la Salud (Publicación científica núm. 547), 1994:3-31.
3. Wendel S, Brener Z, Camargo ME, Rassi A. Chagas disease (American Tripanosomosis): Its impact on transfusion and clinical medicine. Sao Paulo, Ed. ISBT; 1992:1-3.
4. Guzmán-Bracho C, García-García L, Florián-Verdugo J, Guerrero-Martínez S, Torres-Cosme M, Ramírez-Melgarejo et al. Riesgos de transmisión de T. cruzi por transfusión de sangre. Rev Panam Salud Pública 1998;4:590-601.
5. Monteón-Padilla VM, Hernández-Becerril N, Guzmán-Bracho C, Rosales-Encina JL, Reyes-López PA. American tripanosomiasis (Chagas disease) and blood banking in Mexico City: Seroprevalence and its potential transfusional transmission risk. Arch Med Res 1999;30:393-398.
6. Sosa-Jurado F, Zumaquero-Ríos JL, Reyes PA, Cruz-García A, Guzmán-Bracho C, Monteón VM. Factores bióticos y abióticos que determinan la seroprevalencia de anticuerpos contra Trypanosoma cruzi en el municipio de Palmar de Bravo, Puebla, México. Salud Publica Mex 2004;46:39-48.
7. Schmunis AG, Zicker F, Pinheiro F, Brandling-Bennett D. Risk for transfusion-transmitted infectious disease in central and South America. Infect Dis 1998;4:5-11.
8. Moncayo MA. Chagas' disease. Tropical Disease Research. A global partnership. Eight Programme Report. World Health Organization 1987:87-98.
9. Tropical Disease Research. Twelfth programmer report of the UNDP/World bank/WHO Special Programme for Research and Training in Tropical Disease 1995.
10. Camargo ME, Segura EL, Kagan IG, Pacheco-Souza JM, Carvalheiro JR, Yanovsky JF. Normalización del diagnóstico serológico de la enfermedad de Chagas en Las Américas: evaluación de tres años de colaboración. Bol Oficina Sanit Panam 1987; 102:449-463.
11. a sección.
12. Moncayo MA, Luquetti AO. Multicentre double blind study for evaluation of Trypanosoma cruzi defined antigens as diagnosis reagent. Mem Inst Oswaldo Cruz 1990;85:489-495.
13. Guzmán-Bracho C. Producción y caracterización parcial de un péptido recombinante y su valor diagnóstico en la enfermedad de Chagas (tesis de maestría). México, D.F.: Sección de estudios de posgrado e investigación, Escuela Nacional de Ciencias Biológicas-IPN, 1996.
14. pMAL protein fusion and purification system: Expression and purification of protein from cloned genes. New England Biolabs 2004.
15. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:680-685.
16. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc. Natl. Acad Sci USA 1979;76:4350-4354.
17. Renart J, Reiser J, Stark GR. Transfer of proteins from gels to dizobenzyloxymethyl-paper and detection with antisera: A method for studying antibody specificity and antigen structure. Proc Natl Acad Sci USA 1979;76:3116-3120.
18. Ramos-Echevarría A, Monteón VM, Reyes PA. Detección de anticuerpos contra Trypanosoma cruzi en donadores de sangre. Salud Publica Mex 1993;35:56.
19. Schmunis AG. Prevention of transfusional Trypanosoma cruzi infection in latin America. Mem Inst Oswaldo Cruz 1999;94:93-101.
20. Guzmán-Bracho C. Epidemiology of Chagas disease in Mexico: an update. Trends Parasitol 2001;17:372-376.
21. Da Silveira JF, Setsu-Umezawa E, Luquetti AO. Chagas disease: recombinant Trypanosoma cruzi antigens for serological diagnosis. Trends Parasitol 2001;17:286-291.
22. Umezawa ES, Bastos SF, Camargo ME, Yamauchi LM, Santos MR, González A et al. Evaluation of recombinant antigens for serodiagnosis of Chagas' disease in South and Central America. J Clin Microbiol 1999;37:1554-1560.
23. Coura JR, Fernández O, Arboleda M, Barrett TV, Carrara N, Degrave W et al. Human infection by Trypanosoma rangeli in the Brazilian Amazon. Trans R Soc Trop Med Hyg 1996;90:278-279.
24. Vissocci REM, Cavazzana M, Okamura H, Tagata EC, Jankevicius SI, Jankevicius JV. Evaluation of the western blot in the confirmatory serologic diagnosis of Chagas' disease. Am J Trop Med Hyg 1998;59:750-756.
25. Rangel-Flores H, Sánchez B, Mendoza-Duarte J, Barnabé C, Brentère FS, Ramos C et al. Serologic and parasitologic demonstration of Trypanosoma cruzi infections in an urban area of central Mexico: Correlation with electrocardiographic alterations. Am J Trop Med Hyg 2001; 65:887-895.
26. Kenney JS, Hughes BW, Masada MP, Allison AC. Influence of adjuvants on the quantity, affinity, isotype and epitope specificity of murine antibodies. J Immunol Methods 1989;121:157-166.
27. Lövgren-Bengtsson K. Preparation and use of adjuvants. En: Kaufmann SHE, Kabelitz D, ed. Methods in Microbiology: Immunology of infection. Nueva York: Academic Press, 1998;vol.:25.
28. Schechter M, Nogueira N. Variations induced by different methodologies in Trypanosoma cruzi surface antigen profiles. Mol Biochem Parasitol 1988;29:37-46.
29. Silva AMM, Brodskyn CI, Takehara HA, Mota I. Differences in the antigenic profiles of bloodstream and cell culture derived trypomastigotes of Trypanosoma cruzi. Rev Inst Med Trop Sao Paulo 1989;31:146-150.
30. Vidal-Acosta V, Ibáñez-Bernal S, Martínez-Campos C. Infección natural de chinches Triatominae con Trypanosoma cruzi asociadas a la vivienda humana en México. Salud Publica Mex 2000;42:496-503.
31. Dumontiel E. Update on Chagas disease in México. Salud Publica Mex 1999;41:322-327.
32. Sánchez-Guillen MC, Bernabé C, Guégan JF, Tibayrenc M, Velásquez-Rojas M, Martínez-Munguía J et al. High prevalence anti-Trypanosoma cruzi antibodies, among blood donors in the state of Puebla, a nonendemic area of Mexico. Mem Inst Oswaldo Cruz 2002;97:947-952.